Clinical Trial Update: BL-8040 Addition to Consolidation Therapy in AML Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating BL-8040 added to consolidation therapy in patients with Acute Myeloid Leukemia; the current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BL-8040

Snippet

Sponsor: Dr. Petra Tschanter | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN